Predicting mortality and morbidity after elective cardiac surgery using vasoactive and inflammatory biomarkers with and without the EuroSCORE model

Chest

Volumn 146, Issue 5, 2014, Pages 1310-1318

  Schoe, Abraham ^a   Schippers, Emile F ^a   Ebmeyer, Stefan ^b   Struck, Joachim ^b   Klautz, Robert J M ^a   De Jonge, Evert ^a   Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; COPEPTIN; ENDOTHELIN 1; PROADRENOMEDULLIN; PROCALCITONIN;

AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; ELECTIVE SURGERY; EUROSCORE MODEL; FEMALE; HEART DISEASE; HEART SURGERY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL MORTALITY; BLOOD; FOLLOW UP; GERMANY; INFLAMMATION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; SURVIVAL RATE; TRENDS;

AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INFLAMMATION; MALE; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84910011556     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2615     Document Type: Article

References (31)

1. New York State Department of Health. Coronary Artery Bypass Surgery in New York State 1996-1998. Albany, NY: New York State Department of Health; 2001.
2. New York State Department of Health. Adult Cardiac Surgery in New York State 2003-2005. Albany, NY: New York State Department of Health; 2008.
3. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9-13.
4. Nilsson J, Algotsson L, Höglund P, Lührs C, Brandt J. Comparison of 19 pre-operative risk stratifi cation models in open-heart surgery. Eur Heart J. 2006;27(7):867-874.
5. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358(20):2148-2159.
6. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358(20):2107-2116.
7. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631-2639.
8. Becker KL, Nylén ES, White JC, Müller B, Snider RHJ Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in infl ammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89(4):1512-1525.
9. Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000;28(9):3171-3176.
10. Madershahian N, Wittwer T, Strauch J, et al. Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg. 2008;23(5):468-473.
11. Ishimitsu T, Ono H, Minami J, Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther. 2006;111(3):909-927.
12. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005;51(10):1823-1829.
13. Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res. 2007;76(1):8-18.
14. Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem. 2006;52(6):1144-1151.
15. Jochberger S, Velik-Salchner C, Mayr VD, et al. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med. 2009;35(3):489-497.
16. Goldsmith, SR. The role of vasopressin in congestive heart failure. Cleve Clin J Med. 2006;73(suppl 3):S19-S23.
17. . Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112-119.
18. McGrath MF, de Bold AJ . Determinants of natriuretic peptide gene expression. Peptides. 2005;26(6):933-943.
19. . Khan SQ, Dhillon O, Kelly D, et al. Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival aft er acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008;51(19):1857-1864.
20. Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem. 2004;50(1):234-236.
21. Mathis G. Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem. 1993;39(9):1953-1959.
22. Steinbach G, Rau B, Debard AL, et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med. 2004;42(4):440-449.
23. Caruhel P, Mazier C, Kunde J, Morgenthaler NG, Darbouret B. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin Biochem. 2009;42(7-8):725-728.
24. Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.
25. . Kitamura K, Kangawa K, Eto T. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech. 2002;57(1):3-13.
26. Weitzberg E, Ahlborg G, Lundberg JM . Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle. Clin Physiol. 1993;13(6):653-662.
27. Krzemiński K, Cybulski G, Ziemba A, Nazar K. Cardiovascular and hormonal responses to static handgrip in young and older healthy men. Eur J Appl Physiol. 2012;112(4):1315-1325.
28. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-744.
29. Biancari F, Vasques F, Mikkola R, Martin M, Lahtinen J, Heikkinen J. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2012;93(6):1930-1935.
30. Carnero-Alcázar M, Silva Guisasola JA, Reguillo Lacruz FJ, et al. Validation of EuroSCORE II on a single-centre 3800 patient cohort. Interact Cardiovasc Thorac Surg. 2013;16(3):293-300.
31. Barili F, Pacini D, Capo A, et al. Does EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J. 2013;34(1):22-29.